TT&A is advising Leo Investment Holdings Pte. Ltd. and Quadria Capital India Fund III (both Quadria affiliate entities) on the IPO of Aragen Life Sciences Limited comprising of a fresh issue of such number of equity shares of face value of ₹10 each (“Equity Shares”) amounting to ₹8,000 million and offer for sale of up to 27,329,192 Equity Shares by the selling shareholders.

TT&A team: Abhinav Kumar – Partner and Indira Satish – Senior Associate